The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lisocabtagene maraleucel (liso-cel) as second-line (2L) therapy for R/R large B-cell lymphoma (LBCL) in patients (pt) not intended for hematopoietic stem cell transplantation (HSCT): Primary analysis from the phase 2 PILOT study.
 
Alison Sehgal
Speakers' Bureau - OncLive; Peerview
Research Funding - Juno Therapeutics; Kite/Gilead; Miltenyi Biotec
 
Daanish Hoda
No Relationships to Disclose
 
Peter A. Riedell
Honoraria - Novartis
Consulting or Advisory Role - Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Takeda; Verastem
Speakers' Bureau - Bayer; Kite, a Gilead company
Research Funding - Bristol-Myers Squibb/Celgene; Calibr; Kite, a Gilead company; MorphoSys; Novartis
 
Nilanjan Ghosh
Consulting or Advisory Role - Adaptive Biotechnologies; AstraZeneca; Beigene; Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; Karyopharm Therapeutics; Loxo/Lilly; Novartis; Pharmacyclics/Janssen; Roche/Genentech; Seagen; TG Therapeutics
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Epizyme; Kite/Gilead; Pharmacyclics/Janssen
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Morphosys (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Mehdi Hamadani
Honoraria - Celgene
Consulting or Advisory Role - ADC Therapeutics; Gamida Cell; Genmab; Incyte; Kite/Gilead; MorphoSys; Novartis; Omeros; Puma Biotechnology (I); Seagen; Verastem
Speakers' Bureau - ADC Therapeutics; AstraZeneca; BeiGene; Genzyme; Kite/Gilead
Research Funding - Astellas Pharma; Genzyme; Genzyme; Otsuka; Spectrum Pharmaceuticals; Takeda
 
Gerhard Hildebrandt
Stock and Other Ownership Interests - Abbvie; Aetna; Aimmune; ANGI Homeservices; Axim Biotechnologies; Bayer; Bluebird Bio; Bristol-Myers Squibb/Medarex; Cardinal Health; CareTrust Reit; Celgene; Cellectis; Charlotte's Web; Clovis Oncology; crispr therapeutics; CVS Health; Endocyte; GW Pharmaceuticals; IDEXX Laboratories; Immunomedics; Insys Therapeutics; Johnson & Johnson; Juno Therapeutics; Kite, a Gilead company; Medical Properties Trust; Moderna Therapeutics; Novartis; Pfizer; Procter & Gamble; Sangamo Bioscience; Scotts Miracle-Gro; Vertex
Consulting or Advisory Role - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Incyte; Incyte; Incyte; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Karyopharm Therapeutics; Kite, a Gilead company; Morphosys; Pfizer; Seagen
Research Funding - AstraZeneca; Incyte; Jazz Pharmaceuticals; Pharmacyclics; Takeda
Travel, Accommodations, Expenses - Astellas Pharma; Falk Foundation; Falk Foundation; Falk Foundation; Incyte; Incyte; Incyte; Jazz Pharmaceuticals; Kite, a Gilead company; Pfizer; Takeda
 
John E. Godwin
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - MacroGenics
Speakers' Bureau - Abbvie; Bristol-Myers Squibb
 
Patrick Michael Reagan
Consulting or Advisory Role - Kite, a Gilead company
Research Funding - Genentech/Roche; Seagen
 
Nina D. Wagner-Johnston
Consulting or Advisory Role - Epizyme; Grunenthal; Karyopharm Therapeutics; Seagen
Research Funding - Acerta Pharma (Inst); ADC Therapeutics (Inst); Astex Pharmaceuticals (Inst); Genentech (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis/Pfizer (Inst); Regeneron (Inst)
 
James Essell
Speakers' Bureau - Bristol-Myers Squibb; Kite, a Gilead Company
 
Rajneesh Nath
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Actinium Pharmaceuticals
 
Scott R. Solomon
No Relationships to Disclose
 
Rebecca Champion
Consulting or Advisory Role - ADC Therapeutics; BeiGene
Speakers' Bureau - Bristol-Myers Squibb
 
Edward Licitra
No Relationships to Disclose
 
Suzanne Fanning
Consulting or Advisory Role - Abbvie; Amgen; Genentech; Incyte; Pharmacyclics
Speakers' Bureau - Bristol-Myers Squibb; Sanofi; T6 pharma; Takeda
 
Neel K. Gupta
Honoraria - Incyte
Research Funding - Bristol-Myers Squibb
 
Ronald L. Dubowy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb; Cellectis; Compugen; Gilead Sciences; Synairgen
Patents, Royalties, Other Intellectual Property - BMS
 
Aleco D’Andrea
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lei Wang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Leo I. Gordon
Stock and Other Ownership Interests - Zylem
Consulting or Advisory Role - Epizyme; Gilead Sciences; Janssen Oncology; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Zylem